Tiny OncoSec Surges on Promising Phase II Melanoma Data Post author:Sam Post published:November 7, 2017 Post category:BioPharma The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting. Source: BioSpace You Might Also Like <b>ADC Bio</b> To Invest $11 Million On Bioconjugation Facility September 26, 2017 Vapourtec Expands With New Headquarters And Plans For Job Creation April 13, 2017 Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017
Theratechnologies Announces New Findings With The Investigational Antiretroviral Ibalizumab And With EGRIFTA (Tesamorelin For Injection) July 23, 2017